3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
3
Unknown
1
Terminated
1
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
3
Spondylarthritis
1
Cardiovascular Diseases
1
Interventions
Adalimumab
13
Etanercept
8
Methotrexate
7
Rituximab
6
Abatacept
6
tocilizumab
5
golimumab
5
tofacitinib
4
olokizumab
4
Certolizumab Pegol
4
Tumor Necrosis Factor Inhibitors
3
Infliximab
3
Saline Solution
2
Antirheumatic Agents
2
upadacitinib
1
secukinumab
1
sarilumab
1
mavrilimumab
1
baricitinib
1
Vitamin D
1
Vaccines
1
TACI receptor-IgG Fc fragment fusion protein
1
Syringes
1
Sulfasalazine
1
Sodium Chloride
1
Radioimmunodetection
1
RC-18
1
Pharmaceutical Preparations
1
Lysine Acetyltransferase 5
1
Leflunomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
Arthritis, Rheumatoid
×
Tumor Necrosis Factor Inhibitors
×
Clear all
NCT04798287
2022-06-22
STAR-RA-Cancer
Brigham and Women's Hospital
Completed
105,711 enrolled
NCT04529902
2021-11-23
DREAM
Brigham and Women's Hospital
Completed
63,013 enrolled
NCT01548768
2020-11-27
RHYTHM
Columbia University
Phase 4
Completed
149 enrolled
15 charts